Elevated Levels of Transforming Growth Factor a and Epidermal Growth Factor Receptor Messenger RNA Are Early Markers of Carcinogenesis in Head and Neck Cancer

Cancer Research

Volumn 53, Issue 15, 1993, Pages 3579-3584

  Tweardy, David J ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 0027183870     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Davis, S., and Severson, R.K. Increasing incidence of cancer of the tongue in the US among young adults. Lancet, 2: 910-911, 1987.
2. Hakulinen, T., Anderson, A.A., Malker, B., Pukkala, B., Schou, G., and Tulinius, H. Trends in cancer incidence in the Nordic countries. A collaborative study of the five nordic cancer center registries. Acta Pathol. Microbiol. Immunol. Scand., 288 (Suppl.): 1-151, 1986.
3. McFarlane, G.J., Boyle, P., and Scully, C. Rising mortality from cancer of the tongue in young Scottish males. Lancet, 2: 912, 1987.
4. McGeady, M.L., Kerby, S., Shankar, V., Ciardiello, F., Salomon, D., and Seidman, M. Infection with a TGF-± retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. Oncogene, 4: 1375-1382, 1989.
5. Derynk, R., Goeddel, D.V., Ullrich, A., et al. Synthesis of messenger RNAs for transforming growth factors a and ß and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
6. Partridge, M., Green, M.R., Langdon, J.D., and Feldman, M. Production of TGF-± and TGF-ß by altered keratinocytes, skin and oral squamous cell carcinomas-potential autocrine regulation of normal and malignant epithelial cell production. Br. J. Cancer, 60: 542-548, 1989.
7. Yoshida, K., Kyo, E., Tsuda, T., et al. EGF and TGF-±, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Int. J. Cancer, 45: 131-135, 1990.
8. Todd, R., Donoff, B.R., Gertz, R. et al. TGF-± and EGF-receptor mRNAs in human oral cancers. Carcinogenesis (Lond.), 10: 1553-1556, 1989.
9. Weichselbaum, R.R., Dunphy, E.J., Beckett, M.A., et al. Epidermal growth factor gene amplification and expression in head and neck cancer cell lines. Head Neck, 11: 437-442, 1989.
10. Mydlo, J.H., Michaeli, J., Crodon-Cardo, C., Goldenberg, A.S., Heston, W. D. W., and Fair, W.R. Expression of transforming growth factor a and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue. Cancer Res., 49: 3407-3411, 1989.
11. Shirasuna, K., Hayashido, Y., Sugiyama, M., Yoshioka, H., and Matsuya, T. Immunohistochemical localization of epidermal growth factor (EGF) and EGF receptor in human oral mucosa and its malignancy. Virchows Arch. Pathol. Anat., 418: 349-353, 1991.
12. Kawamoto, T., Takahashi, K., Nishi, M., Kimura, T., Matsumura, T., and Taniguchi, S. Quantitative assay of epidermal growth factor receptor in human squamous cell carcinomas of the oral region by an avidin-biotin method. Jpn. J. Cancer. Res., 82: 403-410, 1991.
13. Maxwell, S.A., Sacks, P.G., Gutterman, J.U., and Gallick, G.E. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous cell carcinomas of the head and neck. Cancer Res., 49: 1130-1137, 1989.
14. Mukaida, H., Toi, M., Hirai, T., Yamashita, Y., and Toge, T. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer (Phila.), 68: 142-148, 1991.
15. Yasui, W., Hata, J., Yokozaki, H., et al. Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int. J. Cancer, 41: 211-217, 1988.
16. Lacroix, H., Igelhart, J.D., Skinner, M.A., and Kraus, M.H. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene, 4: 145-151, 1989.
17. Ishitoya, J., Toriyama, M., Oguchi, N., et al. Gene amplification and overexpression of EGF receptor in squamous cell carcinoma of the head and neck. Br. J. Cancer, 59: 559-562, 1989.
18. Ozawa, S., Masakazu, U., Ando, N., Abe, O., Hirai, M., and Shimizu, N. Stimulation by EGF of the growth of EGF receptor-hyperproducing tumor cells in athymic mice. Int. J. Cancer, 40: 706-710, 1987.
19. Todd, R., Chou, M.Y., Matossian, K., Gallagher, G.T., Donoff, R.B., and Wong, D.T.W. Cellular sources of transforming growth factor alpha in human oral cancer. J. Dent. Res., 70: 917-923, 1991.
20. Sacchi, M., Snyderman, C.H., Heo, D.S., et al. Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2. Cancer Res., 50: 3113-3118, 1990.
21. Heo, D.S., Snyderman, C.H., Gollin, S.M., et al. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49: 5167-5175, 1989.
22. Chirgwin, J.M., Praybyla, A.E., McDonald, R.J., and Rutter, J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
23. Lehrach, H., Diamond, D., Wozney, J.M., and Boedtker, H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry, 16: 4743-4751, 1977.
24. Church, G.M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
25. Ullrich, A., Coussens, J.S., Hayflick, J.S., et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 806-810, 1984.
26. Derynck, R., Roberts, A.B., Winkler, M.E., et al. Human transforming growth factor a: precursor structure and expression in E. coli. Cell, 38: 287-297, 1984.
27. Hall, J.L., Dudley, L., Dobner, P.R., Lewis, S.A., and Cowan, N.J. Identification of two human ß-tubulin isotypes. Mol. Cell. Biol., 3: 854-862, 1983.
28. Maniatis, T., Fritsch, E.F., and Sambrook, J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor. NY: Cold Spring Harbor Laboratory, 1982.
29. Southern. E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
30. Merlino. G.T., Xu, Y., Ishi, S., and Clark, A.J.L. Amplification and enhanced expression of the epidermal growth factor receptor gene in A431 human carcinoma cells. Science (Washington DC), 224: 417-419, 1984.
31. Ullrich, A., Coussens, L., Hay flick, J.S., et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 418-425, 1984.
32. Minna, J.D. Genetic events in the pathogenesis of lung cancer. Chest, 96 (Suppl.): 17s-23s, 1989.
33. Derynck, R. Transforming growth factor a. Cell, 54: 593-595, 1988.
34. Maiden, L.T., Novak, U., and Burgess, A.W. Expression of transforming growth factor a messenger RNA in the normal and neoplastic gastro-intestinal tract. Int. J. Cancer, 43: 380-384, 1989.
35. Beauchamp. R.D., Barnard, J.A., McCutchen, C.M., et al. Localization of transforming growth factor a and its receptor in gastric mucosal cells: implications for a regulatory role in acid secretion and mucosal renewal. J. Clin. Invest., 84: 1017-1023, 1989.
36. Slaughter, D.P., Southwick, H. W., and Smejkal, W. “Field cancerization” in oral stratified squamous epithelium, clinical implications of multicentric origin. Cancer (Phila.), 5: 963-968, 1953.
37. Strong, M.S., Inceze, J., and Vaughan, C.W. Field cancerization in the aerodigestive tract-its etiology, manifestation, and significance. J. Otolaryngol., 13: 131-136, 1984.
38. Hong, W.K., Endicott, J., Itri, L.M., et al. 13 cis-retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
39. Hong, W.K., Lippman, S.M., Itri, L.M., et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
40. Hudson, L.G., Santon, J.B., Glass, C.K., and Gill, G.N. Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promotor expression. Cell, 62: 1165-1175, 1990.
41. Dmitrovsky, E., Moy, D., Miller, W.H., Jr., Li, A., and Masui, H. Retinoic acid causes a decline in TGF-± expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res., 5: 233-239, 1990.
42. Kim, J.S., Steck, P.A., Gallick, G.E., et al. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. J. Natl. Cancer Inst. Monogr., 13: 101-110, 1992.
43. Waldmann, T.A., Goldman, C.K., Bongiovanni, K.F., et al. Therapy of patients with human T-cell lymphotropic virus I-induced adult leukemia with anti-tac, a monoclonal antibody to the receptor for interleukin-2. Blood, 72: 1805-1816, 1988.
44. Masui, H., Moroyama, T., and Mendelson, J. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes. Cancer Res., 46: 5592-5598, 1986.
45. Divgi, C.R., Welt, S., Kris, M., et al. Phase I and imaging trial of indium Ill-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst., 83: 97-104, 1991.